Collectively, our results establish MINAR1 as a key regulator of seizure susceptibility, likely via Gαs-cAMP-dependent modulation of SST<sup>+</sup> interneurons, offering a molecular framework for developing targeted epilepsy therapies. This evidence concerns the gene MINAR1 and epilepsy.